- Home
- GH vs SIM Comparison
GH vs SIM Comparison
Compare GH & SIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GH
- SIM
- Stock Information
- Founded
- GH 2011
- SIM 1969
- Country
- GH United States
- SIM Mexico
- Employees
- GH N/A
- SIM N/A
- Industry
- GH Medical Specialities
- SIM Steel/Iron Ore
- Sector
- GH Health Care
- SIM Industrials
- Exchange
- GH Nasdaq
- SIM Nasdaq
- Market Cap
- GH 4.9B
- SIM 4.1B
- IPO Year
- GH 2018
- SIM 1993
- Fundamental
- Price
- GH $98.28
- SIM $29.26
- Analyst Decision
- GH Strong Buy
- SIM
- Analyst Count
- GH 22
- SIM 0
- Target Price
- GH $74.32
- SIM N/A
- AVG Volume (30 Days)
- GH 3.4M
- SIM 582.0
- Earning Date
- GH 10-29-2025
- SIM 10-27-2025
- Dividend Yield
- GH N/A
- SIM N/A
- EPS Growth
- GH N/A
- SIM N/A
- EPS
- GH N/A
- SIM 0.94
- Revenue
- GH $902,569,000.00
- SIM $1,698,258,820.00
- Revenue This Year
- GH $33.95
- SIM N/A
- Revenue Next Year
- GH $25.77
- SIM N/A
- P/E Ratio
- GH N/A
- SIM $31.37
- Revenue Growth
- GH 30.38
- SIM N/A
- 52 Week Low
- GH $28.45
- SIM $22.15
- 52 Week High
- GH $101.57
- SIM $31.00
- Technical
- Relative Strength Index (RSI)
- GH 77.88
- SIM 63.18
- Support Level
- GH $88.88
- SIM $27.58
- Resistance Level
- GH $97.51
- SIM $30.00
- Average True Range (ATR)
- GH 4.94
- SIM 0.31
- MACD
- GH 1.89
- SIM 0.25
- Stochastic Oscillator
- GH 88.05
- SIM 76.88
About GH Guardant Health Inc.
Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
About SIM Grupo Simec S.A.B. de C.V.
Grupo Simec SAB de CV is a diversified producer, processor and distributor of SBQ steel and structural steel products with production and commercial operations. The group's SBQ products are used across a range of engineered end-user applications, including axles, hubs, and crankshafts for automobiles and light trucks, machine tools, and off-highway equipment. Its structural steel products are used in the non-residential construction market and other construction applications. Its segments are Mexico, Brazil, and the United States. The maximum of its sales is from the Mexico segment.